Indie Asset Partners, LLC Invitae Corp Transaction History

Indie Asset Partners, LLC

  • $129 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$24.31 - $33.6 $188,402 - $260,400
-7,750 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$26.09 - $40.4 $39,787 - $61,610
-1,525 Reduced 16.44%
7,750 $261,000
Q1 2021

May 13, 2021
BUY
$33.06 - $56.93 $13,224 - $22,772
400 Added 4.51%
9,275 $354,000
Q4 2020

Feb 09, 2021
BUY
$39.09 - $57.4 $346,923 - $509,425
8,875 New
8,875 $371,000

Others Institutions Holding NVTA

# of Institutions
31
Shares Held
2.08M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Indie Asset Partners, LLC Portfolio

Follow Indie Asset Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email